Antifungal Therapeutic Drug Monitoring Practices: Results of an Emerging Infections Network Survey.

ABSTRACT: In a survey of 523 infectious disease specialists, a moderate to high percentage reported using any antifungal therapeutic drug monitoring (TDM) during itraconazole (72%), posaconazole (72%), and voriconazole (90%) treatment, and a low to moderate percentage reported using any antifungal TDM during prophylaxis (32%, 55%, and 65%, respectively). Long turnaround times for send-out TDM testing and logistical difficulties were frequent barriers.

SUBMITTER: Benedict K 

PROVIDER: S-EPMC10533201 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature